BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

416 related articles for article (PubMed ID: 9001292)

  • 1. Respiratory disease trends in the Pulmonary Complications of HIV Infection Study cohort. Pulmonary Complications of HIV Infection Study Group.
    Wallace JM; Hansen NI; Lavange L; Glassroth J; Browdy BL; Rosen MJ; Kvale PA; Mangura BT; Reichman LB; Hopewell PC
    Am J Respir Crit Care Med; 1997 Jan; 155(1):72-80. PubMed ID: 9001292
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Respiratory illness in persons with human immunodeficiency virus infection. The Pulmonary Complications of HIV Infection Study Group.
    Wallace JM; Rao AV; Glassroth J; Hansen NI; Rosen MJ; Arakaki C; Kvale PA; Reichman LB; Hopewell PC
    Am Rev Respir Dis; 1993 Dec; 148(6 Pt 1):1523-9. PubMed ID: 8256894
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bacterial pneumonia in persons infected with the human immunodeficiency virus. Pulmonary Complications of HIV Infection Study Group.
    Hirschtick RE; Glassroth J; Jordan MC; Wilcosky TC; Wallace JM; Kvale PA; Markowitz N; Rosen MJ; Mangura BT; Hopewell PC
    N Engl J Med; 1995 Sep; 333(13):845-51. PubMed ID: 7651475
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Natural history of opportunistic disease in an HIV-infected urban clinical cohort.
    Moore RD; Chaisson RE
    Ann Intern Med; 1996 Apr; 124(7):633-42. PubMed ID: 8607591
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A decline in the pulmonary diffusing capacity does not indicate opportunistic lung disease in asymptomatic persons infected with the human immunodeficiency virus. Pulmonary Complications of HIV Infection Study Group.
    Kvale PA; Rosen MJ; Hopewell PC; Markowitz N; Hansen N; Reichman LB; Wallace JM; Glassroth J; Fulkerson W; Meiselman L
    Am Rev Respir Dis; 1993 Aug; 148(2):390-5. PubMed ID: 8102043
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomized trial of the discontinuation of primary and secondary prophylaxis against Pneumocystis carinii pneumonia after highly active antiretroviral therapy in patients with HIV infection. Grupo de Estudio del SIDA 04/98.
    Lopez Bernaldo de Quiros JC; Miro JM; Peña JM; Podzamczer D; Alberdi JC; Martínez E; Cosin J; Claramonte X; Gonzalez J; Domingo P; Casado JL; Ribera E;
    N Engl J Med; 2001 Jan; 344(3):159-67. PubMed ID: 11172138
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug smoking, Pneumocystis carinii pneumonia, and immunosuppression increase risk of bacterial pneumonia in human immunodeficiency virus-seropositive injection drug users.
    Caiaffa WT; Vlahov D; Graham NM; Astemborski J; Solomon L; Nelson KE; Muñoz A
    Am J Respir Crit Care Med; 1994 Dec; 150(6 Pt 1):1493-8. PubMed ID: 7952605
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discontinuation of secondary prophylaxis against Pneumocystis carinii pneumonia in patients with HIV infection who have a response to antiretroviral therapy. Eight European Study Groups.
    Ledergerber B; Mocroft A; Reiss P; Furrer H; Kirk O; Bickel M; Uberti-Foppa C; Pradier C; D'Arminio Monforte A; Schneider MM; Lundgren JD;
    N Engl J Med; 2001 Jan; 344(3):168-74. PubMed ID: 11188837
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The rate of serious bacterial infections among HIV-infected children with immune reconstitution who have discontinued opportunistic infection prophylaxis.
    Nachman S; Gona P; Dankner W; Weinberg A; Yogev R; Gershon A; Rathore M; Read JS; Huang S; Elgie C; Hudgens K; Hughes W
    Pediatrics; 2005 Apr; 115(4):e488-94. PubMed ID: 15772172
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discontinuation of primary prophylaxis against Pneumocystis carinii pneumonia in HIV-1-infected adults treated with combination antiretroviral therapy. Swiss HIV Cohort Study.
    Furrer H; Egger M; Opravil M; Bernasconi E; Hirschel B; Battegay M; Telenti A; Vernazza PL; Rickenbach M; Flepp M; Malinverni R
    N Engl J Med; 1999 Apr; 340(17):1301-6. PubMed ID: 10219064
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictors of Pneumocystis carinii pneumonia in HIV-infected persons. Pulmonary Complications of HIV Infection Study Group.
    Stansell JD; Osmond DH; Charlebois E; LaVange L; Wallace JM; Alexander BV; Glassroth J; Kvale PA; Rosen MJ; Reichman LB; Turner JR; Hopewell PC
    Am J Respir Crit Care Med; 1997 Jan; 155(1):60-6. PubMed ID: 9001290
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HIV and the lung.
    Wallace JM
    Curr Opin Pulm Med; 1998 May; 4(3):135-41. PubMed ID: 9675515
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trends in the incidence of outcomes defining acquired immunodeficiency syndrome (AIDS) in the Multicenter AIDS Cohort Study: 1985-1991.
    Muñoz A; Schrager LK; Bacellar H; Speizer I; Vermund SH; Detels R; Saah AJ; Kingsley LA; Seminara D; Phair JP
    Am J Epidemiol; 1993 Feb; 137(4):423-38. PubMed ID: 8096356
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prophylaxis against Pneumocystis carinii pneumonia among children with perinatally acquired human immunodeficiency virus infection in the United States. Pneumocystis carinii Pneumonia Prophylaxis Evaluation Working Group.
    Simonds RJ; Lindegren ML; Thomas P; Hanson D; Caldwell B; Scott G; Rogers M
    N Engl J Med; 1995 Mar; 332(12):786-90. PubMed ID: 7862183
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A study of chest infections in HIV seropositive patients in Kuala Lumpur.
    Wood E; Cheong I; Lee C
    Int J Clin Pract; 1998; 52(1):23-6. PubMed ID: 9536563
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intensive care of patients with HIV infection: utilization, critical illnesses, and outcomes. Pulmonary Complications of HIV Infection Study Group.
    Rosen MJ; Clayton K; Schneider RF; Fulkerson W; Rao AV; Stansell J; Kvale PA; Glassroth J; Reichman LB; Wallace JM; Hopewell PC
    Am J Respir Crit Care Med; 1997 Jan; 155(1):67-71. PubMed ID: 9001291
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced in vivo human immunodeficiency virus-1 replication in the lungs of human immunodeficiency virus-infected persons with Pneumocystis carinii pneumonia.
    Koziel H; Kim S; Reardon C; Li X; Garland R; Pinkston P; Kornfeld H
    Am J Respir Crit Care Med; 1999 Dec; 160(6):2048-55. PubMed ID: 10588627
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidemiology and risk of pulmonary disease.
    Rosen MJ
    Semin Respir Infect; 1999 Dec; 14(4):301-8. PubMed ID: 10638509
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HIV infection/acquired immunodeficiency syndrome at Siriraj Hospital, 2002: time for secondary prevention.
    Anekthananon T; Ratanasuwan W; Techasathit W; Rongrungruang Y; Suwanagool S
    J Med Assoc Thai; 2004 Feb; 87(2):173-9. PubMed ID: 15061301
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Acute pneumonia and cell-mediated immunity in patients with HIV infection].
    Luzzati R; Cazzadori A; Malena M; Mazzi R; Danzi MC; Ciaffoni S; Concia E; Bassetti D
    Minerva Med; 1993 Mar; 84(3):95-101. PubMed ID: 8492971
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.